Clinical Trial Information Request for Protocol 25-736 Title A Phase 2A, Open-Label, Multi-Center Study of Tafasitamab in Adult Participants with Primary Autoimmune Blood Cell Disorders PI Site Directions: Type your name, contact email and phone number (optional) into the boxes below then click Save to Submit your request for information about this study. Name Email Phone